Dr Ebtihal Mustafa
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
25 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Abstract 4065: Unveiling drivers of esophageal adenocarcinoma with CRISPR pooled screen and single-cell RNA-sequencing
DOI: 10.1158/1538-7445.am2025-40652024
Conference Proceedings
DNA hypermethylation markers of upper gastrointestinal adenocarcinoma: Preliminary results of systematic review
2024
Conference Proceedings
Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions
DOI: 10.1158/1538-8514.SYNTHLETH24-PR0072024
Conference Proceedings
Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions
DOI: 10.1158/1538-8514.SYNTHLETH24-A0062024
Journal article
Selective inhibition of CDK9 in triple negative breast cancer
DOI: 10.1038/s41388-023-02892-32024
Journal article
Modelling esophageal adenocarcinoma and Barrett’s esophagus with patient-derived organoids
DOI: 10.3389/fmolb.2024.13820702023
Conference Proceedings
Loss of SMAD4 unleashes mTOR and increases dependency on cap-dependent translation in esophageal tumorigenesis
DOI: 10.1158/1535-7163.TARG-23-A176
RECENT SCHOLARLY WORKS
2023
Journal article
Levels of Selective Oxidative Stress Markers and Antioxidant Enzymes in the Blood of Hubble-Bubble Smokers
DOI: 10.35516/jmj.v57i1.4372021
Journal article
Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase
DOI: 10.26402/jpp.2021.2.092021
Conference Proceedings
Abstract PS11-40: A novel and highly selective CDK9 inhibitor (D11) suppresses proliferation of triple negative breast cancer cells
DOI: 10.1158/1538-7445.sabcs20-ps11-40